Your browser doesn't support javascript.
loading
Generalizable neuromarker for autism spectrum disorder across imaging sites and developmental stages: A multi-site study.
Itahashi, Takashi; Yamashita, Ayumu; Takahara, Yuji; Yahata, Noriaki; Aoki, Yuta Y; Fujino, Junya; Yoshihara, Yujiro; Nakamura, Motoaki; Aoki, Ryuta; Ohta, Haruhisa; Sakai, Yuki; Takamura, Masahiro; Ichikawa, Naho; Okada, Go; Okada, Naohiro; Kasai, Kiyoto; Tanaka, Saori C; Imamizu, Hiroshi; Kato, Nobumasa; Okamoto, Yasumasa; Takahashi, Hidehiko; Kawato, Mitsuo; Yamashita, Okito; Hashimoto, Ryu-Ichiro.
  • Itahashi T; Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan.
  • Yamashita A; Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan.
  • Takahara Y; Graduate School of Information Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Yahata N; Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan.
  • Aoki YY; Laboratory for Drug Discovery and Disease Research, SHIONOGI & CO., LTD, Osaka, Japan.
  • Fujino J; Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan.
  • Yoshihara Y; Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, Chiba, Japan.
  • Nakamura M; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Aoki R; Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan.
  • Ohta H; Department of Psychiatry, Aoki Clinic, Tokyo, Japan.
  • Sakai Y; Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan.
  • Takamura M; Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Ichikawa N; Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Okada G; Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan.
  • Okada N; Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan.
  • Kasai K; Department of Language Sciences, Tokyo Metropolitan University, Tokyo, Japan.
  • Tanaka SC; Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan.
  • Imamizu H; Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan.
  • Kato N; Department of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.
  • Okamoto Y; Department of Neurology, Shimane University, Shimane, Japan.
  • Takahashi H; Department of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.
  • Kawato M; Department of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.
  • Yamashita O; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Hashimoto RI; The International Research Center for Neurointelligence (WPI-IRCN) at The University of Tokyo Institutes for Advanced Study (UTIAS), The University of Tokyo, Tokyo, Japan.
bioRxiv ; 2023 Mar 28.
Article en En | MEDLINE | ID: mdl-37034620
ABSTRACT
Autism spectrum disorder (ASD) is a lifelong condition, and its underlying biological mechanisms remain elusive. The complexity of various factors, including inter-site and development-related differences, makes it challenging to develop generalizable neuroimaging-based biomarkers for ASD. This study used a large-scale, multi-site dataset of 730 Japanese adults to develop a generalizable neuromarker for ASD across independent sites (U.S., Belgium, and Japan) and different developmental stages (children and adolescents). Our adult ASD neuromarker achieved successful generalization for the US and Belgium adults (area under the curve [AUC] = 0.70) and Japanese adults (AUC = 0.81). The neuromarker demonstrated significant generalization for children (AUC = 0.66) and adolescents (AUC = 0.71; all P<0.05, family-wise-error corrected). We identified 141 functional connections (FCs) important for discriminating individuals with ASD from TDCs. These FCs largely centered on social brain regions such as the amygdala, hippocampus, dorsomedial and ventromedial prefrontal cortices, and temporal cortices. Finally, we mapped schizophrenia (SCZ) and major depressive disorder (MDD) onto the biological axis defined by the neuromarker and explored the biological continuity of ASD with SCZ and MDD. We observed that SCZ, but not MDD, was located proximate to ASD on the biological dimension defined by the ASD neuromarker. The successful generalization in multifarious datasets and the observed relations of ASD with SCZ on the biological dimensions provide new insights for a deeper understanding of ASD.

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article